Kenneth Widder
Fortune : 586 850 $ au 31/05/2026
Fortune : 586 850 $ au 31/05/2026
Kenneth J.
Widder is the founder of FeRx, Inc., founded in 1994.
Dr. Widder was the founder of Santarus, Inc., founded in 1999, and served as Chairman from 2002 to 2004.
Dr. Widder is also the founder of Molecular Biosystems, Inc.,NovaCardia, Inc.,Sytera, Inc...
Dr. Widder currently serves as Director at Meritage Pharma, Inc., Independent Director at Personalis, Inc. since 2023, Director at San Diego Museum of Art, Director at The Vision of Children Foundation, and Independent Director at QuidelOrtho Corp.
since 2014.
Former positions include Chairman & Chief Executive Officer at Converge Medical, Inc., Chief Executive Officer & Director at Sydnexis, Inc. from 2017 to 2022, Executive Chairman at OrphoMed, Inc. from 2017 to 2022, Independent Director at Quidel Corp., Director at Luminous Medical, Inc., Director at Naurex, Inc., Director at eStudySite, Inc., Director at Femta Pharmaceuticals, Inc., Director at Aptinyx, Inc., Independent Director at Evoke Pharma, Inc. from 2007 to 2025, Partner at Latterell Venture Partners from 2007 to 2016, and Managing Member at Windamere Venture Partners LLC.
Education includes undergraduate degree from Carleton College in 1974, and graduate and doctorate degrees from Northwestern University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
QUIDELORTHO CORPORATION 0,07 % | 06/06/2026 | 45 073 ( 0,07 % ) | 586 850 $ | 31/05/2026 |
PERSONALIS, INC. -.--% | 12/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| QUIDELORTHO CORPORATION | Directeur/Membre du Conseil | 01/01/2014 |
| PERSONALIS, INC. | Directeur/Membre du Conseil | 14/06/2023 |
The Vision of Children Foundation
The Vision of Children Foundation The Vision of Children Foundation is a non-profit organization based in San Diego, CA. | Directeur/Membre du Conseil | - |
San Diego Museum of Art
San Diego Museum of Art Other Consumer ServicesConsumer Services Operates as an arts museum | Directeur/Membre du Conseil | - |
Meritage Pharma, Inc.
Meritage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription products for the treatment of gastrointestinal and atopic diseases | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| EVOKE PHARMA, INC. | Directeur/Membre du Conseil | 17/12/2025 |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/01/2022 |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Président | - |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Private Equity Investor | 01/01/2016 |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 24 |
|---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, makes and sells ultrasound contrast imaging agents | Health Technology |
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Provides diagnostic healthcare solutions | Health Technology |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Finance |
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing and commercializing pharmaceutical products for the treatment of upper & lower gastrointestinal diseases and disorders | Health Technology |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cardiovascular diseases | Health Technology |
Luminous Medical, Inc.
Luminous Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Provide automated glucose management systems | Electronic Technology |
Evoke Pharma, Inc.
Evoke Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets drugs to treat gastrointestinal | Health Technology |
Meritage Pharma, Inc.
Meritage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription products for the treatment of gastrointestinal and atopic diseases | Health Technology |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Health Technology |
Personalis, Inc.
Personalis, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer genomics company which transforms the development of next-generation therapies | Health Services |
Carleton College
Carleton College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Converge Medical, Inc.
Converge Medical, Inc. Medical SpecialtiesHealth Technology Develops novel medical devices for cardiac surgery | Health Technology |
Windamere Venture Partners LLC
Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners invests in seed and early-stage companies. The firm target companies are product-focused healthcare companies in the areas of emerging pharmaceuticals, specialty pharmaceuticals and medical devices. | Finance |
Sytera, Inc.
Sytera, Inc. BiotechnologyHealth Technology Provides biopharmaceutical services and products | Health Technology |
eStudySite, Inc.
eStudySite, Inc. BiotechnologyHealth Technology Provides clinical trials research services | Health Technology |
FeRx, Inc.
FeRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes magnetic technology for the treatment of cancer | Health Technology |
Femta Pharmaceuticals, Inc.
Femta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics | Health Technology |
San Diego Museum of Art
San Diego Museum of Art Other Consumer ServicesConsumer Services Operates as an arts museum | Consumer Services |
The Vision of Children Foundation
The Vision of Children Foundation The Vision of Children Foundation is a non-profit organization based in San Diego, CA. | |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Aptinyx, Inc.
Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
QuidelOrtho Corp.
QuidelOrtho Corp. Medical SpecialtiesHealth Technology Manufactures in vitro diagnostics products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national